Non-Interventional Study on the Side Effects of Empagliflozin Compared with DPP-4 Inhibitors in Patients with Type 2 Diabetes in New Zealand First published 14/09/2023 Last updated 02/04/2024 EU PAS number:EUPAS106713 Study Ongoing